arrow
S

Simon Tanguay

mcgill university
H指数:47
被引数:7,467

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

45 Targeting Lysyl Oxidase Inhibits Tumor Progression in Clear Cell Renal Cell Carcinoma

45 靶向赖氨酰氧化酶可抑制透明细胞肾细胞癌的肿瘤进展

2026-09-020
OAAI
Outcomes and Predictors of Recurrence and Survival in Surgically Resected Localized Chromophobe Renal Cell Carcinoma: Results from the Canadian Kidney Cancer Information System (CKCis)

局部嫌色性肾细胞癌手术切除后的复发结局与预测因素及生存情况:加拿大肾癌信息系统(CKCis)的结果

2026-04-050
OAAI
Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in Canada

加拿大老年患者晚期肾细胞癌一线治疗的实际管理与临床结局

2026-02-010
PRE
Response to Zheng et al. “Advances and Challenges in Diagnostic Strategies for HLRCC—A Letter to the Editor Regarding the Study by Ouchene et al. on HLRCC"

对郑等人“HLRCC诊断策略的进展与挑战——关于Ouchene等人HLRCC研究的致编辑函”的回应

2025-12-030
PRE
defining cancer initiating cells and their vulnerabilities in renal cell carcinoma

定义肾细胞癌中的癌症起始细胞及其易损性

2025-10-010
OAAI
Increased prevalence of renal cysts in hereditary leiomyomatosis and renal cell cancer: A cross-sectional magnetic resonance imaging-based study

遗传性平滑肌瘤病和肾细胞癌中肾囊肿患病率的增加:一项基于磁共振成像的横断面研究

2025-06-190
PRE
Response to Chen et al., “Comment on “Assessing the diagnostic metrics of cutaneous leiomyomas in hereditary leiomyomatosis and renal cell cancer syndrome: An observational study””

对Chen等人的回应,“对‘评估遗传性平滑肌瘤病和肾细胞癌综合征中皮肤平滑肌瘤的诊断指标:一项观察性研究’的评论”

2025-06-140
PRE
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative

Terry Fox Research Institute马拉松希望癌症中心网络:一项全加拿大的精准肿瘤学倡议

2025-04-010
PRE
Assessing the diagnostic metrics of cutaneous leiomyomas in hereditary leiomyomatosis and renal cell cancer syndrome: An observational study

评估遗传性平滑肌瘤病和肾细胞癌综合征中皮肤平滑肌瘤的诊断指标:一项观察性研究

2025-02-190
OAAI
Is there a minimum percentage of sarcomatoid component required to affect outcomes of localised renal cell carcinoma?

是否有最小百分比的肉瘤样成分需要影响局部肾细胞癌的结果?

2024-12-040
OAAI
Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic Therapies

接受一线全身治疗的有或没有肉瘤样特征的转移性肾细胞癌患者临床结局的真实世界评估

2024-06-012
OA
Outcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian Centers

转移性肾细胞癌患者的细胞减灭性肾切除术的结果: 来自加拿大中心的真实数据

2022-11-015
PRE